| Product Code: ETC13117644 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
In 2024, the Netherlands continued to rely on imports for pneumococcal vaccines, with top exporters being Belgium, Hungary, USA, Japan, and Sweden. Despite a high Herfindahl-Hirschman Index (HHI) indicating market concentration, the compound annual growth rate (CAGR) from 2020 to 2024 stood at a steady 3.85%. However, there was a significant decline in growth rate from 2023 to 2024, dropping by -42.93%. This fluctuation suggests a potential shift in market dynamics or regulatory changes impacting the import landscape for pneumococcal vaccines in the Netherlands.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Pneumococcal Vaccines Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Pneumococcal Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Pneumococcal Vaccines Market - Industry Life Cycle |
3.4 Netherlands Pneumococcal Vaccines Market - Porter's Five Forces |
3.5 Netherlands Pneumococcal Vaccines Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Netherlands Pneumococcal Vaccines Market Revenues & Volume Share, By Vaccine Technology, 2021 & 2031F |
3.7 Netherlands Pneumococcal Vaccines Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Netherlands Pneumococcal Vaccines Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Netherlands Pneumococcal Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Government initiatives promoting vaccination programs |
4.2.2 Increasing awareness about the benefits of pneumococcal vaccines |
4.2.3 Rising prevalence of pneumococcal diseases in the Netherlands |
4.3 Market Restraints |
4.3.1 High cost associated with pneumococcal vaccines |
4.3.2 Limited access to healthcare facilities in certain regions |
4.3.3 Vaccine hesitancy or misinformation among some segments of the population |
5 Netherlands Pneumococcal Vaccines Market Trends |
6 Netherlands Pneumococcal Vaccines Market, By Types |
6.1 Netherlands Pneumococcal Vaccines Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Pneumococcal Vaccines Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Netherlands Pneumococcal Vaccines Market Revenues & Volume, By Conjugate, 2021 - 2031F |
6.1.4 Netherlands Pneumococcal Vaccines Market Revenues & Volume, By Polysaccharide, 2021 - 2031F |
6.1.5 Netherlands Pneumococcal Vaccines Market Revenues & Volume, By Combination, 2021 - 2031F |
6.1.6 Netherlands Pneumococcal Vaccines Market Revenues & Volume, By Live Attenuated, 2021 - 2031F |
6.1.7 Netherlands Pneumococcal Vaccines Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 Netherlands Pneumococcal Vaccines Market, By Vaccine Technology |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Pneumococcal Vaccines Market Revenues & Volume, By Protein-based, 2021 - 2031F |
6.2.3 Netherlands Pneumococcal Vaccines Market Revenues & Volume, By Recombinant, 2021 - 2031F |
6.2.4 Netherlands Pneumococcal Vaccines Market Revenues & Volume, By Inactivated, 2021 - 2031F |
6.2.5 Netherlands Pneumococcal Vaccines Market Revenues & Volume, By mRNA-based, 2021 - 2031F |
6.2.6 Netherlands Pneumococcal Vaccines Market Revenues & Volume, By Others, 2021 - 2031F |
6.3 Netherlands Pneumococcal Vaccines Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Pneumococcal Vaccines Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Netherlands Pneumococcal Vaccines Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.3.4 Netherlands Pneumococcal Vaccines Market Revenues & Volume, By Government, 2021 - 2031F |
6.3.5 Netherlands Pneumococcal Vaccines Market Revenues & Volume, By NGOs, 2021 - 2031F |
6.3.6 Netherlands Pneumococcal Vaccines Market Revenues & Volume, By Others, 2021 - 2031F |
6.4 Netherlands Pneumococcal Vaccines Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Netherlands Pneumococcal Vaccines Market Revenues & Volume, By Immunization, 2021 - 2031F |
6.4.3 Netherlands Pneumococcal Vaccines Market Revenues & Volume, By Disease Prevention, 2021 - 2031F |
6.4.4 Netherlands Pneumococcal Vaccines Market Revenues & Volume, By Pediatric Vaccination, 2021 - 2031F |
6.4.5 Netherlands Pneumococcal Vaccines Market Revenues & Volume, By Elderly Care, 2021 - 2031F |
6.4.6 Netherlands Pneumococcal Vaccines Market Revenues & Volume, By Others, 2021 - 2031F |
7 Netherlands Pneumococcal Vaccines Market Import-Export Trade Statistics |
7.1 Netherlands Pneumococcal Vaccines Market Export to Major Countries |
7.2 Netherlands Pneumococcal Vaccines Market Imports from Major Countries |
8 Netherlands Pneumococcal Vaccines Market Key Performance Indicators |
8.1 Number of individuals vaccinated annually |
8.2 Rate of vaccination coverage in target demographics |
8.3 Percentage increase in public funding for vaccination programs |
8.4 Number of healthcare facilities offering pneumococcal vaccines |
8.5 Growth in partnerships between pharmaceutical companies and healthcare providers for vaccine distribution and promotion |
9 Netherlands Pneumococcal Vaccines Market - Opportunity Assessment |
9.1 Netherlands Pneumococcal Vaccines Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Netherlands Pneumococcal Vaccines Market Opportunity Assessment, By Vaccine Technology, 2021 & 2031F |
9.3 Netherlands Pneumococcal Vaccines Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Netherlands Pneumococcal Vaccines Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Netherlands Pneumococcal Vaccines Market - Competitive Landscape |
10.1 Netherlands Pneumococcal Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Pneumococcal Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here